---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-296632"
form_type: "8-K/A"
ticker: "AMRX"
cik: "0001723128"
company_name: "Amneal Pharmaceuticals, Inc."
filed_at: "2023-12-15T23:59:59+00:00"
generated_at: "2026-06-07T11:58:41.518632+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "medium"
source: SEC EDGAR
---

# Amneal files corrected bylaws as part of 8-K/A amendment to prior merger filing

## Summary
- Amendment No.1 corrects Exhibit 3.2 (Amended and Restated Bylaws) from Nov 7, 2023 merger.
- No other changes from original 8-K; all other exhibits remain unchanged.
- Original 8-K reported merger agreements and related amendments to employment and governance documents.

## SEC filing metadata
- accession: 0001193125-23-296632
- form_type: 8-K/A
- ticker: AMRX
- cik: 0001723128
- company_name: Amneal Pharmaceuticals, Inc.
- filed_at: 2023-12-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: medium
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1723128/000119312523296632/0001193125-23-296632-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1723128/000119312523296632/d66330d8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-296632
- JSON: https://secwatch.observer/filing/0001193125-23-296632.json
- Plain text: https://secwatch.observer/filing/0001193125-23-296632.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.